IPG Photonics Announces Third Quarter 2026 Financial Results

(NASDAQ: IPGP) IPG Photonics Corporation reported financial results for the third quarter ended September 30, 2026. Revenue for the third quarter was $287.5 million, up 15% from $250.8 million in the prior year period. For the nine months ended September 30, 2026, revenue was $831.6 million, a 14% increase from $729.3 million in the same period of 2025. Gross margin for the third quarter was 40.7%, compared to 39.5% in the prior year, and adjusted gross margin was 41.0%, up from 39.8%. Operating income for the third quarter was $20.8 million, compared to $7.9 million in the prior year, and for the nine months was $17.6 million versus $9.8 million. Net income for the third quarter was $20.3 million, up from $7.5 million, and for the nine months was $27.1 million, up from $17.8 million. Earnings per diluted share for the third quarter were $0.47, compared to $0.18, and for the nine months were $0.63, compared to $0.42. Adjusted EBITDA for the third quarter was $51.5 million, up from $37.0 million, and for the nine months was $135.2 million, up from $101.2 million. Adjusted earnings per diluted share for the third quarter were $0.61, up from $0.35, and for the nine months were $1.49, up from $0.96. Industrial Solutions sales for the third quarter were $239,548,000, up 12%, and Advanced Solutions sales were $47,952,000, up 33%. For the nine months, Industrial Solutions sales were $704,181,000, up 16%, and Advanced Solutions sales were $127,396,000, up 5%. Third quarter revenue of $288 million increased 15% year over year, with Industrial Solutions accounting for 83% of total revenue. Emerging growth products accounted for 52% of total revenue, down from 58% in the prior quarter. By region, sales increased 14% in Asia, 33% in North America, and decreased 1% in Europe year over year. The increase in gross margin was driven by lower product costs and $5.0 million in net tariff refunds, partially offset by lower fixed cost absorption. IPG generated $46 million in cash flow from operations and spent $17 million on capital expenditures in the third quarter. For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0%, and adjusted operating expenses of $91 million to $94 million. The company anticipates adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million. The guidance assumes no contribution from the acquisition of Lumibird Medical, which is expected to close in the fourth quarter. As of September 30, 2026, cash and cash equivalents were $710,688,000, and total assets were $2,472,043,000. Accounts receivable, net, were $191,150,000, and inventories were $337,890,000. Total current liabilities were $257,514,000, and total stockholders' equity was $2,154,948,000. Net cash provided by operating activities for the nine months ended September 30, 2026, was $78,531,000. Purchases of and deposits on property, plant and equipment for the nine months were $54,437,000. The company recorded impairment charges of $17,805,000 and settlement of litigation matters of $13,334,000 in the nine months ended September 30, 2026. The company held a conference call on November 3, 2026, at 10:00 am ET to discuss these results. Dr. Mark Gitin is the Chief Executive Officer of IPG Photonics.